tetano
Editor, Senior Moderator
J Infect. 2020 Feb 25. pii: S0163-4453(20)30087-6. doi: 10.1016/j.jinf.2020.02.010. [Epub ahead of print] [h=1]Recent insights into 2019-nCoV: a brief but comprehensive review.[/h]
Han Q[SUP]1[/SUP], Lin Q[SUP]1[/SUP], Jin S[SUP]2[/SUP], You L[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A novel coronavirus designated as 2019-nCoV hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and multiple countries. Up to 0:00 am February 9, 2020, a total of 37,287 cases have been confirmed infection of 2019-nCoV in China mainland, and 302 cases have also been cumulatively reported from 24 countries. According to the latest data, a total of 813 deaths occurred in China mainland, with the mortality reaching approximately 2.2%. At present, there is no vaccine or specific drugs for human coronavirus, so that it's critical to understand the nature of the virus and its clinical characteristics to response to the 2019-nCoV outbreak. Thus, we summarize the not much but timely reports on the 2019-nCoV in the present study, briefly but comprehensively.
Copyright ? 2020. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] 2019-nCoV; epidemiology; genomic; therapeutic
PMID: 32109444 DOI: 10.1016/j.jinf.2020.02.010
Han Q[SUP]1[/SUP], Lin Q[SUP]1[/SUP], Jin S[SUP]2[/SUP], You L[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A novel coronavirus designated as 2019-nCoV hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and multiple countries. Up to 0:00 am February 9, 2020, a total of 37,287 cases have been confirmed infection of 2019-nCoV in China mainland, and 302 cases have also been cumulatively reported from 24 countries. According to the latest data, a total of 813 deaths occurred in China mainland, with the mortality reaching approximately 2.2%. At present, there is no vaccine or specific drugs for human coronavirus, so that it's critical to understand the nature of the virus and its clinical characteristics to response to the 2019-nCoV outbreak. Thus, we summarize the not much but timely reports on the 2019-nCoV in the present study, briefly but comprehensively.
Copyright ? 2020. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] 2019-nCoV; epidemiology; genomic; therapeutic
PMID: 32109444 DOI: 10.1016/j.jinf.2020.02.010